CD8A and neoplasm: It has been reported that the ratio of pro-inflammatory cytokines to immunosuppressive cytokines and the ratio of CD8+ T cells to Tregs, tumor-associated macrophages (TAMs), and MDSCs are related to the responsiveness to ICB immunotherapy [35].